Global Digital PCR Market Size Study & Forecast, by Type (Droplet Digital PCR, Chip-based Digital PCR, and Others), Product (Instruments and Reagents & Consumables), Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), End-user (Hosp

The Global Digital PCR Market is valued at approximately USD 0.7 billion in 2024 and is anticipated to expand at a stellar CAGR of over 23.1% during the forecast period from 2025 to 2035. Digital PCR (dPCR), a breakthrough in molecular diagnostics, has redefined how genetic material is quantified, providing unmatched sensitivity, precision, and reproducibility. As a refinement of conventional PCR methods, digital PCR divides a sample into thousands of partitions and amplifies DNA within each, enabling absolute quantification and detecting low-level targets with unparalleled accuracy. This transformative technology is gaining rapid traction in fields ranging from oncology and infectious disease detection to genetic disorder screening and biopharmaceutical applications. The rising burden of chronic diseases, growing acceptance of personalized medicine, and increasing demand for early and precise diagnostics are serving as major catalysts for market growth.

Digital PCR’s unique ability to detect rare mutations and its robust performance in complex samples where traditional qPCR might falter is dramatically changing diagnostic and research landscapes. For instance, in oncology, dPCR is becoming an essential tool for detecting circulating tumor DNA (ctDNA) and monitoring minimal residual disease (MRD). In infectious diseases, it has proven to be critical in identifying viral load even at minute concentrations, as seen in its widespread use during the COVID-19 pandemic. Moreover, expanding investments in genomic research, increasing funding for life science projects, and the integration of advanced automation technologies into PCR workflows are collectively accelerating the global adoption of digital PCR platforms. However, the relatively higher cost of dPCR systems and consumables, coupled with the need for skilled personnel, may hinder mass adoption in resource-limited settings.

Regionally, North America commanded the largest share of the Digital PCR market in 2024 and is expected to maintain its dominance throughout the forecast period. This growth is underpinned by a strong base of biotechnology companies, advanced healthcare infrastructure, aggressive R&D spending, and early adoption of innovative diagnostic technologies. The United States, in particular, is a front-runner in clinical genomics and precision medicine. Europe follows closely, supported by a robust research environment and extensive government initiatives in cancer genomics and infectious disease surveillance. The Asia Pacific region, however, is poised to witness the fastest growth between 2025 and 2035, driven by increasing healthcare awareness, rising investment in biotechnology sectors, growing genomic studies, and favorable government support in countries like China, India, and Japan. Technological penetration and healthcare modernization are further expected to fuel the market expansion across APAC.

Major market player included in this report are:
• Thermo Fisher Scientific
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Merck KGaA
• Stilla Technologies
• Fluidigm Corporation
• JN Medsys
• Sysmex Corporation
• Combinati Inc.
• Biomérieux SA
• Agilent Technologies
• Takara Bio Inc.
• Standard BioTools Inc.

Global Digital PCR Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Type:
• Droplet Digital PCR
• Chip-based Digital PCR
• Others

By Product:
• Instruments
• Reagents & Consumables

By Indication:
• Infectious Diseases
• Oncology
• Genetic Disorders
• Others

By End-user:
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Industries
• Clinical Laboratories
• Academic & Research Organizations

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more